Knockdown of glycolytic genes (HK2, PFKP, ALDOA, PGAM1, ENO1, ENO2, and PDK1) strongly inhibits GBM growth [46], indicating that key glycolytic enzymes are essential for GBM growth. The gene discussed is ENO1; the disease is glioblastoma.